Stonepine Capital Management, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Stonepine Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $2.47 Million - $3.66 Million	-200,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$23.12 - $29.91 $5.14 Million - $6.65 Million	-222,310 Reduced 52.64%	200,000 $4.79 Million
Q1 2021 May 14, 2021	BUY	$14.69 - $42.57 $6.2 Million - $18 Million	422,310 New	422,310 $10.8 Million
Q4 2019 Feb 13, 2020	SELL	$10.31 - $17.81 $340,570 - $588,317	-33,033 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$11.6 - $21.67 $383,182 - $715,825	33,033 New	33,033 $383,000
Q4 2018 Feb 13, 2019	SELL	$16.21 - $24.06 $2.24 Million - $3.32 Million	-138,100 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$8.0 - $22.11 $1.1 Million - $3.05 Million	138,100 New	138,100 $3.05 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.